Foxeel Shutterstock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thai study looks at CoronaVac vaccine vs. natural immunity to SARS-COV-2 variants The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that was first reported in Wuhan, China in December 2019. SARS-CoV-2, which has a very high rate of transmission, is the causal agent of the coronavirus disease 2019 (COVID-19). Several vaccines have been developed against SARS-CoV-2, several of which have received emergency use authorization (EUA) from global regulatory bodies. As a result, vaccination programs have commenced in many countries, with over 3.6 billion doses th...

The Future of Vaccines World Immunization Week offers the scientific community a platform to showcase the most forward-thinking vaccination developments. This sharing of information allows scientists to educate themselves on the directions that vaccinations are taking and how they will improve the health of people across the globe, which is particularly relevant to preventing new diseases such as COVID-19 and ensuring old ones don’t reemerge. World Immunization Week gives key insights into the key advancements in the field; here, we discuss the current innovations in vaccine technology that...